생성: 2026-06-09 06:31 · Rebeauty Genome Lab · 한국인 특화 분석 + Google DeepMind AI 통합
| 유전자 | 내 변이 | AM 변이 | 병원성 | 평균 점수 |
|---|---|---|---|---|
| RYR1 | 1 | 95,722 | 63,678 | 0.691 |
| HERC2 | 1 | 91,846 | 52,386 | 0.620 |
| AHNAK | 1 | 111,910 | 40,329 | 0.463 |
| FBN1 | 1 | 54,568 | 32,288 | 0.640 |
| MUC5AC | 1 | 107,426 | 29,445 | 0.406 |
| SCN9A | 1 | 37,810 | 22,287 | 0.636 |
| AKAP9 | 1 | 74,233 | 22,224 | 0.413 |
| TCHH | 1 | 36,917 | 17,653 | 0.552 |
| DCHS2 | 1 | 65,289 | 17,127 | 0.376 |
| COL1A1 | 2 | 27,835 | 15,512 | 0.606 |
| rsID | 내 GT | 예측 요약 |
|---|---|---|
| rs1001179 | CT | 조절 영향 예측 (max|effect|=0.297, 4 tracks) |
| rs1014063 | GG | 조절 영향 예측 (max|effect|=0.084, 4 tracks) |
| rs1015352 | CC | 조절 영향 예측 (max|effect|=0.153, 4 tracks) |
| rs1042522 | CG | 조절 영향 예측 (max|effect|=0.189, 4 tracks) |
| rs1042602 | CC | 조절 영향 예측 (max|effect|=0.072, 4 tracks) |
| rs1042713 | AG | 조절 영향 예측 (max|effect|=0.096, 4 tracks) |
| rs1042714 | CG | 조절 영향 예측 (max|effect|=0.099, 4 tracks) |
| rs10488683 | CT | 조절 영향 예측 (max|effect|=0.261, 4 tracks) |
| rs10502861 | CC | 조절 영향 예측 (max|effect|=0.309, 4 tracks) |
| rs1050501 | TC | 조절 영향 예측 (max|effect|=0.179, 4 tracks) |
| rs1052053 | AG | 조절 영향 예측 (max|effect|=4.030, 4 tracks) |
| rs1057343 | CT | 조절 영향 예측 (max|effect|=0.321, 4 tracks) |
| 유전자 | 변이 | rsID | ClinVar 분류 |
|---|---|---|---|
| EDAR | V370A | rs3827760 | Benign |
| ALDH2 | E504K | rs671 | drug response |
| IL10 | - | rs1800896 | Pathogenic |
| FLG | R501* | rs61816761 | Pathogenic/Likely pathogenic |
| APOE | R176C | rs7412 | drug response |
| TP53 | P72R | rs1042522 | Benign |
| SLCO1B1 | V174A | rs4149056 | drug response |
| BCHE | D98G | rs1799807 | Pathogenic/Likely pathogenic |
| MTHFR | A222V | rs1801133 | drug response |
| F2 | - | rs1799963 | Pathogenic/Likely pathogenic/Pathogenic, |
| VKORC1 | - | rs9923231 | drug response |
| F5 | R534Q | rs6025 | drug response |
| ALAD | K59N | rs1800435 | Benign/Likely benign |
| MTHFR | E429A | rs1801131 | Benign/Likely benign; other |
| TERT | - | rs2736100 | Benign |
| CYP2C9 | - | rs1057910 | drug response; other |
| RTEL1 | - | rs6010620 | Benign |
| SLC24A5 | - | rs1426654 | association |
| ACE | - | rs1799752 | drug response |
| CYP3A5 | - | rs776746 | association; drug response; risk factor |
| rsID | Gene | GT | 해석 | 약물 |
|---|---|---|---|---|
| rs1142345 | TPMT | TT | 정상 | azathioprine, 6-mercaptopurine |
| rs2844682 | HLA-B*15:02 tag | AA | 낮은 *15:02 보유 가능성 | carbamazepine, phenytoin |
| rs4149056 | SLCO1B1 | TT | 정상 | simvastatin, atorvastatin |
| rs4244285 | CYP2C19 | GA | *1/*2 — 부분 활성화 (intermediate metabolizer) | clopidogrel, omeprazole |
| rs429358 | APOE | TT | ε2 또는 ε3 (낮은 위험) | statin response |
| rs4680 | COMT | AA | Met/Met — 통증 민감, 도파민 느린 분해 ('worrier') | pain modifier |
| rs671 | ALDH2 | GA | Heterozygous (*1/*2) — 술 약함, 얼굴 빨개짐 (한국인 25%) | alcohol |
| rs7412 | APOE | CC | ε3 또는 ε4 (보통-위험) | |
| rs762551 | CYP1A2 | AC | Intermediate (*1F/*1A) — 평균 | caffeine |
| rs9923231 | VKORC1 | AA | 와파린 용량 ~75% 감소 권장 (출혈 위험) | warfarin |